Lawyers for Merck & Co. told the Supreme Court on Monday that investors waited too late and didn’t do all of the necessary investigations to sue the drugmaker over whether it properly warned about the risks of its blockbuster painkiller Vioxx.
Appeals court throws out Merck's appeal of Vioxx award
Merck & Co.'s appeal of a $4.5 million jury award to a New Jersey man who blamed his heart attack on the company's Vioxx painkiller was dismissed by an appeals court, lawyers for the man's family said.
TRENTON -- Merck & Co. is on the verge of settling its most serious personal injury lawsuits over Vioxx, but the drugmaker still faces substantial litigation over the onetime blockbuster painkiller it yanked from the market in 2004 because of cardiovascular risks. Click here for more infoDoctor Critical of Vioxx Leaving Clinic
Dr. Eric Topol, a world-renowned cardiologist who was one of the first scientists to raise doubts about the safety of the pain reliever Vioxx, will leave the Cleveland Clinic and its top-ranked heart center to teach at nearby Case Western Reserve University, the Case medical school announced Thursday.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved